Kanagawa, Japan

Kousuke Hidaka


 

Average Co-Inventor Count = 6.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kanagawa, JP (2015 - 2019)
  • Fujisawa, JP (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Kousuke Hidaka: Innovator in Pharmaceutical Research

Introduction

Kousuke Hidaka is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target various diseases. With a total of 5 patents to his name, Hidaka's work is paving the way for new therapeutic options.

Latest Patents

Hidaka's latest patents include innovative compounds with specific inhibitory actions. One notable invention is an IP6K inhibitor, which aims to provide a heterocyclic compound that exhibits IP6K inhibitory action. This compound is expected to be useful as a prophylactic or therapeutic agent for diseases such as cardiac failure and diabetes. Another significant patent involves a heterocyclic compound that has an HDAC inhibitory action, which is useful for treating autoimmune diseases, inflammatory diseases, and various cancers, including neurodegenerative diseases.

Career Highlights

Throughout his career, Kousuke Hidaka has worked with notable organizations, including Takeda Pharmaceutical Company Limited. His experience in the pharmaceutical industry has allowed him to focus on developing innovative solutions for complex health issues.

Collaborations

Hidaka has collaborated with esteemed colleagues such as Akira Kaieda and Naoki Ishii. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kousuke Hidaka's contributions to pharmaceutical research are noteworthy, with his innovative patents addressing critical health challenges. His work continues to inspire advancements in therapeutic options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…